0001144204-14-015047.txt : 20140312
0001144204-14-015047.hdr.sgml : 20140312
20140312134539
ACCESSION NUMBER: 0001144204-14-015047
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140312
FILED AS OF DATE: 20140312
DATE AS OF CHANGE: 20140312
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEOGENOMICS INC
CENTRAL INDEX KEY: 0001077183
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734]
IRS NUMBER: 742897368
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
BUSINESS PHONE: 9419231949
MAIL ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC
DATE OF NAME CHANGE: 19990120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VAN OORT DOUGLAS M
CENTRAL INDEX KEY: 0001518733
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35756
FILM NUMBER: 14686987
MAIL ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
4
1
form466866_20140312014515-.xml
X0306
4
2014-03-12
0
0001077183
NEOGENOMICS INC
NEO
0001518733
VAN OORT DOUGLAS M
C/O NEOGENOMICS, INC.
12701 COMMONWEALTH DRIVE SUITE 9
FORT MYERS
FL
US 33913
1
1
0
0
Chairman and CEO
Common Stock
2014-03-12
4
A
0
187500
1.05
A
991456
I
Trust by Self
Common Stock
2014-03-12
4
A
0
187500
1.05
A
187500
I
By Conundrum Capital Partners, LLC
Common Stock
8600
D
Warrants (Right to Buy)
1.05
2014-03-12
4
A
0
375000
1.05
A
2009-03-16
2014-03-15
Common Stock
0
250000
D
Stock Option (Right to buy)
1.71
2013-02-14
2017-02-14
Common Stock
0
800000
D
Stock Option (Right to buy)
0.8
2009-12-31
2016-03-15
Common Stock
0
1000000
D
Conundrum Capital Partners, LLC is a limited partnership 50% owned by Mr. VanOort. Mr. VanOort is a managing partner of Condundrum Capital Partners, LLC.
On March 16, 2009 Mr. VanOort was granted a warrant to purchase 625,000 shares. Of this total 375,000 shares became vested and exercisable and 250,000 shares are not vested and exercisable. On March 12, 2014 Mr. VanOort exercised 375,000 warrants and received 375,000 shares of NeoGenomics common stock.
On February 14, 2012 Mr. VanOort was granted options to purchase 800,000 shares. These shares vest equally over each of the first four anniversaries of the grant date.
On March 15, 2009 Mr. VanOort was granted options to purchase 1,000,000 shares. The grant was comprised of 500,000 time based options and 500,000 performance based options. The first date that vesting became available was December 31, 2009.
/s/ Douglas M. VanOort
2014-03-12